THE EFFECTIVENESS OF BOTULINUM THERAPY FOR POSTURAL ABNORMALITY IN PARKINSON’S DISEASE
https://doi.org/10.34822/2304-9448-2022-3-83-87
Abstract
The study aims to analyze a clinical case of movement disorders in a patient with Parkinson’s disease and a method for its treatment using botulinum toxin. Materials and methods. A clinical case of Parkinson’s disease is presented, movement disorders are analyzed, a protocol for the introduction of botulinum toxin into target muscles by means of computed tomography navigation is described, and the results of treatment are evaluated. Results. The use of botulinum toxin therapy proved to be an effi cient treatment for postural anomalies in the clinical case presented.
About the Authors
L. P. Smertina
Surgut State University, Surgut
Russian Federation
Russian Federation
Candidate of Sciences (Medicine), Associate Professor
E-mail: Smertina@yandex.ru
A. A. Kabanov
Surgut Regional Clinical Hospital, Surgut
Russian Federation
Russian Federation
Radiologist
E-mail: kaa.xray@gmail.com
References
1. Doherty K. M., van de Warrenburg B. P., Peralta M. C. et al. Postural Deformities in Parkinson’s Disease // Lancet Neurol. 2011. Vol. 10, Is. 6. P. 538–549.
2. Srivanitchapoom P., Hallett M. Camptocormia in Parkinson’s Disease: Definition, Epidemiology, Pathogenesis and Treatment Modalities // J Neurol Neurosurg Psychiatry. 2016. Vol. 87, Is. 1. P. 75–85.
3. Barone P., Santangelo G., Amboni M., Pellecchia M. T., Vitale C. Pisa Syndrome in Parkinson’s Disease and Parkinsonism: Clinical Features, Pathophysiology, and Treatment // Lancet Neurol. 2016. Vol. 15, Is. 10. P. 1063–1074.
4. Vorovenci R. J., Biundo R., Antonini A. Therapy-Resistant Symptoms in Parkinson’s Disease // J Neural Transm (Vienna). 2016. Vol. 123, Is. 1. P. 19–30.
5. Bonneville F., Bloch F., Kurys E. et al. Camptocormia and Parkinson’s Disease: MR Imaging // Eur Radiol. 2008. Vol. 18. P. 1710–1719.
6. Frazzitta G., Balbi P., Gotti F. et al. Pisa Syndrome in Parkinson’s Disease: Electromyographic Aspects and Implications for Rehabilitation // Parkinsons Dis. 2015. Vol. 2015. P. 437190.
7. Yao M.-S., Zhou L.-C., Tan Y.-Y. et al. Gait Characteristics and Brain Activity in Parkinson’s Disease with Concomitant Postural Abnormalities // Aging and Disease. 2020. Vol. 11, Is. 4. P. 791–800.
8. Ashour R., Jankovic J. Joint and Skeletal Deformities in Parkinson’s Disease, Multiple System Atrophy and Progressive Supranuclear Palsy // Mov Disord. 2006. Vol. 21, Is. 11. P. 1856–1863.
9. Agari T., Date I. Spinal Cord Stimulation for the Treatment of Abnormal Posture and Gait Disorder in Patients with Parkinson’s Disease // Neurol Med Chir. 2012. Vol. 52, Is. 7. P. 470–474.
10. Azher S. N., Jankovic J. Camptocormia: Pathogenesis, Classification and Response to Therapy // Neurology. 2005. Vol. 65, Is. 3. P. 355–359.
11. Reichel G., Kirchhofer U., Stenner A. Camptocormia – Segmental Dystonia. Proposal of a New Definition for an Old Disease // Nervenarzt. 2001. Vol. 72, Is. 4. P. 281–285.
12. Salvatori F. M. Injection of the Iliopsoas Muscle with Botulinum Toxin in Camptocormia // Mov Disord. 2009. Vol. 24, Is. 2. P. 316–317.
13. Коваленко А. П. Использование ботулинотерапии для лечения камптокормии у больных с болезнью Паркинсона (клинический случай) // Болезнь Паркинсона и расстройства движения : руководство для врачей / под ред. С. Н. Иллариошкина, О. С. Левина. М. : СовероПресс, 2014. С. 198–200.
Review
For citations:
Smertina L.P., Kabanov A.A. THE EFFECTIVENESS OF BOTULINUM THERAPY FOR POSTURAL ABNORMALITY IN PARKINSON’S DISEASE. Vestnik SurGU. Meditsina. 2022;(3 (53)):83-87. (In Russ.) https://doi.org/10.34822/2304-9448-2022-3-83-87
Views:
165
Email this article 
